Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108264 · ClinicalTrials.gov registry record · Phase 1
Tumor RNA Transfected Dendritic Cell Vaccines
A Phase 1 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00108264: Completed Phase 1 study, sponsored by US Department of Veterans Affairs.
NCT00108264 is a Phase 1 study that has completed, run by US Department of Veterans Affairs. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00108264, a Phase 1 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to use dendritic cells transfected with amplified RNA from autologous tumor cells to develop a vaccine strategy for the treatment of prostate cancer in patients with disseminated disease.
Interventions
- BIOLOGICAL Tumor RNA transfected dendritic cells
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2005-09 |
| Phase | Phase 1 |
What the finished NCT00108264 record still lists
NCT00108264 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Tumor RNA transfected dendritic cells is the first listed.
NCT00108264 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00108264 about?
NCT00108264 is a clinical study titled "Tumor RNA Transfected Dendritic Cell Vaccines". The purpose of this study is to use dendritic cells transfected with amplified RNA from autologous tumor cells to develop a vaccine strategy for the treatment of prostate cancer in patients with disseminated disease.
What is the current status of trial NCT00108264?
This trial is currently completed. It is a Phase 1 study. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00108264?
The interventions under investigation include: Tumor RNA transfected dendritic cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT00108264?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.